Overview
CATX market data
Price History
CATX price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CATX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Perspective Therapeutics' Updated Data On Its [212Pb]VMT-α-NET Program Accepted For Presentation At European Society Of Medical Oncology Congress 2026Benzinga · Jul 17, 2026, 4:24 PM
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · Jul 14, 2026, 12:03 PM
8-K filing — Perspective Therapeutics, Inc. (CATX)SEC EDGAR · Jul 1, 2026, 8:10 PM
Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in MelanomaGlobenewswire Inc · May 21, 2026, 10:15 PM
Perspective Therapeutics Reports Early Response SignalS And Favorable Safety Across Three Radiopharmaceutical Programs At ASCO 2026, Including 29% Response Rate In Advanced Melanoma CohortBenzinga · May 21, 2026, 10:00 PM
Earnings Scheduled For May 11, 2026Benzinga · May 11, 2026, 11:11 AM